REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in preclinical models of asthma, acute lung inflammation and ...
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and ...
Aldeyra submitted the single successful trial to the FDA over the summer and the agency accepted the resubmitted NDA for ...
Senores Pharmaceuticals Ltd said it has acquired a Gujarat-based pharmaceutical company along with five of its drug ...
The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for Aldeyra’s New Drug Application (NDA) for reproxalap for the treatment of dry ...
Representatives of companies including AbbVie, Eli Lilly, Johnson & Johnson and Merck have voiced concerns about the FDA’s ...
Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...
Northeastern University researchers have made a breakthrough drug discovery, developing the first synthetic endogenous ...
The FDA taps J&J drug teclistamab for its National Priority Voucher pilot, enabling expedited review for multiple myeloma treatment.
Over one lakh drugs samples were tested in 2024-25, out of which over 3,000 were declared not of standard quality, the centre ...
Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs: Our Bureau, Bengaluru Tuesday, December 16, 2025, 16:45 Hrs [IST] Senores Pharmaceuticals has entered into a defini ...
An experimental pain-relieving drug delivery method for farm animals using microneedle patches may not have delivered an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback